Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (AHSCT) is a curative treatment for a wide variety of hematological diseases. In 30% of the cases, a geno-identical donor is available. Any other situation displays some level of human leukocyte antigen (HLA) incompatibility between donor and recipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin-Zorman, Sarah, Loiseau, Pascale, Taupin, Jean-Luc, Caillat-Zucman, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981597/
https://www.ncbi.nlm.nih.gov/pubmed/27570526
http://dx.doi.org/10.3389/fimmu.2016.00307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981597/
https://www.ncbi.nlm.nih.gov/pubmed/27570526
http://dx.doi.org/10.3389/fimmu.2016.00307

Ejemplares similares